Position in VTRS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,451,835
+$646,849 QoQ
Shares Held
217,370
+4.7% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#205
of 1,016 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Kendall Capital Management holds $9,113,830 across 5 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (37.9% of the industry book) .
All Filings in VTRS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,451,835 | 217,370 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,804,986 | 207,623 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,609,395 | 209,590 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $1,812,492 | 183,080 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,615,883 | 180,950 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,877,092 | 215,510 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $2,814,011 | 226,025 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,437,751 | 209,970 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,128,870 | 200,270 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,174,691 | 182,135 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,803,303 | 166,510 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $1,326,663 | 134,550 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,089,376 | 109,156 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $781,490 | 81,236 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $664,505 | 59,704 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $319,363 | 37,484 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $155,018 | 14,806 | Shares | Sole | 2022-07-29 | |
| No filing history on record for this holder in this stock. | ||||||